These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Gut microbiota profiles and the role of anti-CdtB and anti-vinculin antibodies in patients with functional gastrointestinal disorders (FGID). Vasapolli R; Schulz C; Schweden M; Casèn C; Kirubakaran GT; Kirste KH; Macke L; Link A; Schütte K; Malfertheiner P Eur J Clin Invest; 2021 Dec; 51(12):e13666. PubMed ID: 34390492 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of a faecal dysbiosis test for irritable bowel syndrome in subjects with and without obesity. Aasbrenn M; Valeur J; Farup PG Scand J Clin Lab Invest; 2018; 78(1-2):109-113. PubMed ID: 29271246 [TBL] [Abstract][Full Text] [Related]
6. The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors. Lin H; Guo Q; Wen Z; Tan S; Chen J; Lin L; Chen P; He J; Wen J; Chen Y Microb Cell Fact; 2021 Dec; 20(1):233. PubMed ID: 34963452 [TBL] [Abstract][Full Text] [Related]
8. Multi-omics Analysis of Gut Microbiota and Metabolites in Rats With Irritable Bowel Syndrome. Liu S; Si C; Yu Y; Zhao G; Chen L; Zhao Y; Zhang Z; Li H; Chen Y; Min L; Zhang S; Zhu S Front Cell Infect Microbiol; 2019; 9():178. PubMed ID: 31192167 [TBL] [Abstract][Full Text] [Related]
9. Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome. Yang M; Zhang L; Hong G; Li Y; Li G; Qian W; Xiong H; Bai T; Song J; Hou X J Gastroenterol Hepatol; 2020 May; 35(5):795-805. PubMed ID: 31674052 [TBL] [Abstract][Full Text] [Related]
10. The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects. Rangel I; Sundin J; Fuentes S; Repsilber D; de Vos WM; Brummer RJ Aliment Pharmacol Ther; 2015 Nov; 42(10):1211-21. PubMed ID: 26376728 [TBL] [Abstract][Full Text] [Related]
11. Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress. Sundin J; Rangel I; Fuentes S; Heikamp-de Jong I; Hultgren-Hörnquist E; de Vos WM; Brummer RJ Aliment Pharmacol Ther; 2015 Feb; 41(4):342-51. PubMed ID: 25521822 [TBL] [Abstract][Full Text] [Related]
12. Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome. Zhu S; Liu S; Li H; Zhang Z; Zhang Q; Chen L; Zhao Y; Chen Y; Gu J; Min L; Zhang S Front Cell Infect Microbiol; 2019; 9():346. PubMed ID: 31681624 [No Abstract] [Full Text] [Related]
13. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome. Chassard C; Dapoigny M; Scott KP; Crouzet L; Del'homme C; Marquet P; Martin JC; Pickering G; Ardid D; Eschalier A; Dubray C; Flint HJ; Bernalier-Donadille A Aliment Pharmacol Ther; 2012 Apr; 35(7):828-38. PubMed ID: 22315951 [TBL] [Abstract][Full Text] [Related]
14. Bile and fat excretion are biomarkers of clinically significant diarrhoea and constipation in irritable bowel syndrome. Vijayvargiya P; Camilleri M; Burton D; Busciglio I; Lueke A; Donato LJ Aliment Pharmacol Ther; 2019 Mar; 49(6):744-758. PubMed ID: 30740753 [TBL] [Abstract][Full Text] [Related]
15. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Jeffery IB; O'Toole PW; Öhman L; Claesson MJ; Deane J; Quigley EM; Simrén M Gut; 2012 Jul; 61(7):997-1006. PubMed ID: 22180058 [TBL] [Abstract][Full Text] [Related]
16. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD. Casén C; Vebø HC; Sekelja M; Hegge FT; Karlsson MK; Ciemniejewska E; Dzankovic S; Frøyland C; Nestestog R; Engstrand L; Munkholm P; Nielsen OH; Rogler G; Simrén M; Öhman L; Vatn MH; Rudi K Aliment Pharmacol Ther; 2015 Jul; 42(1):71-83. PubMed ID: 25973666 [TBL] [Abstract][Full Text] [Related]
17. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study. Halkjær SI; Christensen AH; Lo BZS; Browne PD; Günther S; Hansen LH; Petersen AM Gut; 2018 Dec; 67(12):2107-2115. PubMed ID: 29980607 [TBL] [Abstract][Full Text] [Related]
18. Interplay between bile acid metabolism and microbiota in irritable bowel syndrome. Dior M; Delagrèverie H; Duboc H; Jouet P; Coffin B; Brot L; Humbert L; Trugnan G; Seksik P; Sokol H; Rainteau D; Sabate JM Neurogastroenterol Motil; 2016 Sep; 28(9):1330-40. PubMed ID: 27060367 [TBL] [Abstract][Full Text] [Related]
19. Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome. Yang J; Wang P; Liu T; Lin L; Li L; Kou G; Zhou R; Li P; Li Y BMC Microbiol; 2021 Nov; 21(1):316. PubMed ID: 34773967 [TBL] [Abstract][Full Text] [Related]
20. Gut microbial signatures of patients with diarrhea-predominant irritable bowel syndrome and their healthy relatives. Chen J; Lan H; Li C; Xie Y; Cheng X; Xia R; Ke C; Liang X J Appl Microbiol; 2024 Jun; 135(6):. PubMed ID: 38849305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]